73 filings
8-K
ATXS
Astria Therapeutics Inc
9 Apr 24
Departure of Directors or Certain Officers
8:07am
8-K
ATXS
Astria Therapeutics Inc
25 Mar 24
Other Events
7:37am
8-K
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
8-K
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
8-K
ATXS
Astria Therapeutics Inc
30 Jan 24
Other Events
6:01am
8-K
kvcgsryahbmqd
5 Jan 24
Entry into a Material Definitive Agreement
8:30am
8-K
601kxb 5hwygyy5xy
20 Dec 23
Departure of Directors or Certain Officers
4:30pm
8-K
2etcc
13 Nov 23
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
8:06am
8-K
52jcy5fpvz4188 iq
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
8-K
4u6f88ioowx8ox pfs
12 Oct 23
Other Events
8:00am
8-K
ojh56h
11 Oct 23
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
5:14pm
8-K
vn2v6 2wxg
6 Jun 23
Departure of Directors or Certain Officers
8:00am
8-K
sctd4af04
31 Mar 23
Departure of Directors or Certain Officers
8:00am
8-K
wlvth7vv44582yq
22 Mar 23
Astria Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
8:07am
8-K
xi0drc2gzp
2 Feb 23
Departure of Directors or Certain Officers
4:03pm
8-K
3crv o5fzm7q0x5p6t7
5 Jan 23
Corporate Presentation January 2023 1 Confidential
8:00am
8-K
1ef9t193
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
kzkm u592cgs
15 Dec 22
Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects
6:00am
8-K
l6xo2qd67o g3mor
10 Nov 22
Other Events
4:11pm
8-K
b81efy489f260dle
16 Sep 22
Other Events
4:18pm